GlassScriptPhysician profile
Arun K Gupta
NPI 1619382835
$3,333.53
in general payments reported to CMS, 2019-2025
24 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $30.50 · 2021: $362 · 2022: $126 · 2023: $377 · 2024: $1,441 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,768 · Travel and Lodging: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,768.23 |
| Travel and Lodging | $638.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $882.26 | 2024 | Scopis Ent, Clarifix Cryotherapy Device |
| Aerin Medical INC. | $440.41 | 2019-2025 | |
| Inspire Medical Systems, INC. | $428.26 | 2024-2025 | Inspire |
| Genzyme Corporation | $318.09 | 2021-2025 | |
| Optinose US, INC. | $180.89 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $162.75 | 2022-2025 | Dupixent |
| Itamar Medical INC | $161.17 | 2022-2025 | Watchpatone |
| Becton, Dickinson and Company | $142.99 | 2019 | |
| Amgen INC. | $136.69 | 2021-2025 | |
| Integra Lifesciences Corporation | $79.02 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Takeda Pharmaceuticals U.S.A., INC. | $65.73 | 2021 | |
| Phathom Pharmaceuticals, INC. | $48.59 | 2025 | Voquezna |
| Organogenesis INC. | $46.16 | 2023 | Puraply |
| Hologic Sales and Service, LLC | $45.72 | 2023-2025 | Coolseal Generator |
| Neurent Medical Limited | $34.07 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $33.73 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.74 | 2025 | |
| Ethicon US, LLC | $18.51 | 2025 | Stratafix |
| Xoran Technologies LLC | $16.50 | 2021 | |
| Medtronic, INC. | $15.56 | 2021 | |
| Smith+Nephew, INC. | $14.97 | 2022 | |
| Kaleo, INC. | $14.37 | 2022 | |
| Merck Sharp & Dohme LLC | $12.70 | 2021 | |
| Acclarent, INC | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.